The impact of chronic Epstein-Barr virus infection on the liver graft of pediatric liver transplant recipients: A retrospective observational study.
Masato ShizukuHideya KameiAtsushi YoshizawaYoshinori ItoYasuhiro OguraJunichi YoshikawaNobuhiko KurataKanta JobaraYasuhiro KoderaPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
CHEBV had little adverse effect on the liver graft. Graft fibrosis might have been avoided through optimal dose modification of tacrolimus. Further long-term monitoring is necessary because CHEBV may affect the pediatric liver graft in the long term.